8 Clinical Trials to be Presented at ECR 2017
Hear from investigators of key clinical trials in radiology, who will present preliminary and final results from recent trials that will impact clinical practice.
This year there are two Clinical Trials in Radiology Sessions:
Clinical Trials in Radiology 1
When: Wednesday 1 March
Time: 12:30 - 13:30
Room: M 1
1. Preoperative Breast MRI - MIPA Study
New insights into preoperative breast magnetic resonance imaging (MRI) from the multicentre individual patient analysis (MIPA) study.
2. MICRA trial: Minimally Invasive Complete Response Assessment of the Breast after Neoadjuvant Systemic Therapy
Preliminary results from the MICRA-trial, which aims to find those breast cancer patients in whom surgery of the breast after NST can be omitted, by predicting the presence of a pCR solely on biopsies.
3. Diagnosing Prostate Cancer
Preliminary results from the MULTIPROS study - pre-biopsy multiparametric MRI to predict significant prostate cancer with subsequent randomisation to MRI/US fusion guided biopsy vs transrectal ultrasonography (TRUS) biopsy in the diagnosis of prostate cancer.
4. Screening for Cardiovascular Disease
Is CT screening for cardiovascular disease cost-effective? The ROBINSCA trial plans to find out. At ECR the first recruitment results are being presented.
Clinical Trials in Radiology 2
When: Thursday 2 March 2
Time: 12:30 - 13:30
Room: M 1
5. Is MRgFUS safe and effective to treat paediatric patients with osteoid osteoma?
Evaluation of the effectiveness and safety of magnetic resonance-guided focused ultrasound (MRgFUS) to treat osteoid osteoma in paediatric patients.
6. Iodixanol versus iopromide in contemporary coronary CT angiography: lumen opacification and effect on heart rhythm: ISO-COR trial
When using contemporary cardiac-CT protocols can equal coronary lumen opacification be achieved with iso-osmolar and low-osmolar contrast media, when injected at the same iodine delivery rate? The ISO-COR trial also investigated the effect on heart rate.
7. Comparison of Pretest Probability with Prevalence of Obstructive Coronary Artery Disease Using Invasive Coronary Angiography or Computed Tomography Angiography
The DISCHARGE trial aims to investigate methods to improve individually tailored decision-making according to chest pain guidelines for patients suspected of having obstructive CAD.
8. Diagnostic value of novel MRI techniques for the primary staging and restaging of rectal cancer: multicentre study
This trial aimed to evaluate the performance of diffusion-weighted imaging (DWI) and lymph node contrast-enhanced MRI for rectal cancer (re-)staging.
Register for ECR Now
Published on : Thu, 16 Feb 2017
Redefining the Vision of Cardiovascular The LISENDO 880 is Hitachi’s premium 2D/4D diagnostic ultrasound solution for cardiologists in any clinical setting. The LISENDO 880 platform is redefining the vision for cardiac ultrasound by providing exceptional...
About the Affirm® breast biopsy guidance system Our passion to offer innovative interventional tools that advance breast health fueled the development of the Affirm breast biopsy guidance system. This simple add-on to any Hologic 3D Mammography™-capable...
For Interventional Examinations (XA or RF) you can easily identify which angulation ranges were the most exposed and the location of the highest dose point using the incidence map. The Air Kerma point is identified in real-time.Patient care and follow...
THE VEVO MD IS THE WORLD’S FIRST ULTRA HIGH FREQUENCY ULTRASOUND SYSTEM DESIGNED FOR CLINICAL USE WITH FREQUENCIES UP TO 70 MHz. This groundbreaking technology opens up new possibilities for medical imaging that have never been seen before. Whether...
Introducing a new chapter in ultrasound visualization technology. X-Porte was developed from the ground up to incorporate a breakthrough, proprietary beam-forming technology: XDI (Extreme Definition Imaging). This signal analysis algorithm shapes...